C. Daniel Mullins
Impact in
- Family Practice top 1%
- Geriatrics and Gerontology top 1%
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 73
- Healthcare Policy and Management 27
- Pharmaceutical Economics and Policy 24
-
- Healthcare cost, quality, practices 24
- Mental Health and Patient Involvement 19
- Health Policy Implementation Science 17
- Co-authors
- Eberechukwu Onukwugha (42 shared papers)Josephine Mauskopf (17 shared papers)Brian Seal (38 shared papers)Arif Hussain (20 shared papers)Don Husereau (16 shared papers)Stavros Petrou (15 shared papers)Dan Greenberg (15 shared papers)Esther W. de Bekker‐Grob (15 shared papers)
- Journals
- Value in Health (40 papers)Journal of Clinical Oncology (23 papers)PharmacoEconomics (15 papers)Clinical Therapeutics (15 papers)PLoS ONE (6 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
C. Daniel Mullins
350 papers receiving 10.7k citations
C. Daniel Mullins's Hit Papers
Peers
Comparison fields: 5 of 183
- Family Practice 146
- Geriatrics and Gerontology 223
- Economics and Econometrics 1.7k
- General Health Professions 1.2k
- Transplantation 109
Countries citing papers authored by C. Daniel Mullins
This map shows the geographic impact of C. Daniel Mullins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Daniel Mullins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Daniel Mullins more than expected).
Fields of papers citing papers by C. Daniel Mullins
This network shows the impact of papers produced by C. Daniel Mullins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Daniel Mullins. The network helps show where C. Daniel Mullins may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Daniel Mullins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 365 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations Hit paper breakdown → | 2022 | 547 |
| 2 | Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis Hit paper breakdown → | 2007 | 527 |
| 3 | Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer Hit paper breakdown → | 2014 | 518 |
| 4 | Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report Hit paper breakdown → | 2007 | 511 |
| 5 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force Hit paper breakdown → | 2022 | 462 |
| 6 | Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology Hit paper breakdown → | 2012 | 379 |
| 7 | Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making Hit paper breakdown → | 2017 | 334 |
| 8 | Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations Hit paper breakdown → | 2022 | 233 |
| 9 | 2017 | 230 | |
| 10 | 2006 | 223 | |
| 11 | Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations Hit paper breakdown → | 2022 | 215 |
| 12 | 2006 | 209 | |
| 13 | Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations Hit paper breakdown → | 2022 | 154 |
| 14 | 2015 | 142 | |
| 15 | 2017 | 131 | |
| 16 | 2018 | 129 | |
| 17 | 2016 | 103 | |
| 18 | 2005 | 101 | |
| 19 | 2022 | 98 | |
| 20 | 2020 | 91 |
About C. Daniel Mullins
C. Daniel Mullins is a scholar working on Economics and Econometrics, General Health Professions, Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 365 papers that have together received 11.0k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (73 papers), Healthcare Policy and Management (27 papers), Pharmaceutical Economics and Policy (24 papers), Healthcare cost, quality, practices (24 papers), Mental Health and Patient Involvement (19 papers), Health Policy Implementation Science (17 papers), Medication Adherence and Compliance (12 papers) and Colorectal Cancer Treatments and Studies (10 papers). The work is most often cited by research in Family Practice (146 citations), Geriatrics and Gerontology (223 citations), Economics and Econometrics (1.7k citations), General Health Professions (1.2k citations) and Transplantation (109 citations). C. Daniel Mullins has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Eberechukwu Onukwugha, Josephine Mauskopf, Brian Seal, Arif Hussain, Don Husereau, Stavros Petrou, Dan Greenberg, Esther W. de Bekker‐Grob, Sophie Staniszewska and Andrew Briggs. Their work appears in journals such as Value in Health, Journal of Clinical Oncology, PharmacoEconomics, Clinical Therapeutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.